Animal models of spinal cord injury

Topics in Spinal Cord Injury Rehabilitation

Volumn 6, Issue 2, 2000, Pages 1-13

  Blight, A R ^a  

^a ACORDA THERAPEUTICS INC   (United States)

Author keywords

Contusion; Degeneration; Nerve fiber; Regeneration; Spinal cord; Trauma

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTUSION; DISEASE MODEL; HISTOLOGY; LOCOMOTION; NERVE FIBER DEGENERATION; NERVE FIBER REGENERATION; NONHUMAN; REVIEW; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; SPINAL CORD TRANSSECTION;

EID: 0033681923     PISSN: 10820744     EISSN: None     Source Type: Journal    
DOI: 10.1310/2XNY-A824-UCTF-EN4D     Document Type: Review

References (50)

1. An overview of spinal cord injury models
2. Glucocorticoid mechanisms in acute spinal cord injury: A review and therapeutic rationale
3. The neuroprotective pharmacology of methylprednisolone
4. Efficacy of methylprednisolone in acute spinal cord injury
5. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury
6. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-Year follow-up data
7. Opiate antagonist improves neurologic recovery after spinal injury
8. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats
9. Recovery of motor function after spinal cord injury - A randomized, placebo-controlled trial with GM-1 ganglioside
10. Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury
11. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study
12. The endogenous antioxidant glutathione as a factor in the survival of physically injured mammalian spinal cord neurons
13. In vitro investigations of the effects of nonfreezing low temperatures on lesioned and uninjured mammalian spinal neurons
14. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter
15. Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury
16. Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord
17. Spinal cord injury: Facts and figures at a glance
18. Experimental cervical myelopathy. Effects of ischemia and compression of the canine cervical spinal cord
19. Criteria for evaluating spinal cord regeneration experiments
20. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column: A preliminary report
21. A monitored contusion model of spinal cord injury in the rat
22. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection
23. Spinal cord contusion in the rat: Production of graded, reproducible injury groups
24. Validation of the weight-drop contusion model in rats: A comparative study of human spinal cord injury
25. MASCIS evaluation of open field locomotor scores: Effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study
26. An electromechanical spinal injury technique with dynamic sensitivity
27. Spinal cord injury produced by consistent mechanical displacement of the cord in rats: Behavioral and histologic analysis
28. Traumatic spinal cord injury produced by controlled contusion in mouse
29. Spinal cord compression studies: I. Experimental techniques to produce acute and gradual compression
30. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat
31. Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology
32. Histological and functional evaluation of experimental spinal cord injury: Evidence of a stepwise response to graded compression
33. Interaction of contact velocity and cord compression in determining the severity of spinal cord injury
34. Axonal regeneration in spinal cord injury: A perspecrive and new technique
35. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord
36. A sensitive and reliable locomotor rating scale for open field testing in rats
37. Methods to assess the development and recovery of locomotor function after spinal cord injury in rats
38. Objective clinical assessment of motor function after experimental spinal cord injury in the rat
39. A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device
40. A comparison of YM-14673, U-50488H, and nalmefene after spinal cord injury in the rat
41. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX
42. Morphometric analysis of experimental spinal cord injury in the cat: The relation of injury intensity to survival of myelinated axons
43. Cellular morphology of chronic spinal cord injury in the cat: Analysis of myelinated axons by line-sampling
44. Assessment of spinal cord injury by counting corticospinal and rubrospinal neurons
45. Effects of the sodium channel blocker tetrodotoxin on acute white matter pathology after experimental contusive spinal cord injury
46. Three-dimensional computer-assisted analysis of graded contusion lesions in the spinal cord of the rat
47. Two- and three-dimensional computer graphic evaluation of the subacute spinal cord injury
48. Axonal regeneration in the rat spinal cords produced by an antibody against myelin-associated neurite growth inhibitors
49. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury
50. Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury